Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous acetate effects on insulin sensitivity and appetite regulation
NL-OMON21096Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of Sodium Acetate in cardiometabolic risk (CMR) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Effect of intravenous acetate infusion on postprandial glucose metabolism. Started Feb 2020; status: recruiting.
02
Drugs
Sodium Acetate
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on NL-OMON21096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21096.